DENTSPLY SIRONA Inc. XRAY

Healthcare SIC 3843 - Dental Equipment & Supplies NAICS Manufacturing › Miscellaneous Manufacturing › Medical Equipment and Supplies Manufacturing › Dental Equipment and Supplies Manufacturing derived Nasdaq

DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") is the world's largest diversified manufacturer of professional dental products and technologies, with a 139-year history of innovation and service to the dental industry and a vision of improving oral health and continence care globally. Dentsply Sirona develops, manufactures, and markets comprehensive solutions, including technologically advanced dental equipment supported by cloud-enabled software solutions as well as dental products and healthcare consumable products in urology and enterology under a strong portfolio of world-class brands. Dentsply Sirona's innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better, safer, and faster dentistry. Dentsply Sirona's worldwide headquarters is located in Charlotte, North Carolina. The Company's shares of common stock are listed in the United States on the Nasdaq stock market under the symbol XRAY.

Last close 9.43 2026-10-23
Market cap $1.88B 2026-06-30 share count
52-week range 8.32 - 14.76

Valuation FY2025 figures against the last close

P/S0.5x
P/E—
P/FCF18.1x
EV/EBITDA—
Dividend yield6.8%
Diluted EPS-3.00

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • Other Foreign
  • United States
  • Germany
Revenue by geography, 3 categories over 3 years. The same figures are in the table below. FY2025 Other Foreign, FY2025: 2.1B (56.4%) 56% Other Foreign United States, FY2025: 1.2B (32.1%) 32% United States Germany, FY2025: 422M (11.5%) 11% Germany FY2024 Other Foreign, FY2024: 2B (53.7%) 54% United States, FY2024: 1.3B (35.5%) 36% Germany, FY2024: 410M (10.8%) 11% FY2023 Other Foreign, FY2023: 2.1B (52.9%) 53% United States, FY2023: 1.4B (36.2%) 36% Germany, FY2023: 431M (10.9%) 11%
Region FY2025FY2024FY2023
Other Foreign $2.08B $2.04B $2.10B
United States $1.18B $1.35B $1.44B
Germany $422.0M $410.0M $431.0M

As the company reported it, from the “SEGMENT AND GEOGRAPHIC INFORMATION - NET SALES AND LONG LIVED ASSETS BY GEOGRAPHIC LOCATION (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Revenue by segment

  • Essential Dental Solutions
  • Connected Technology Solutions
  • Orthodontic and Implant Solutions
  • Wellspect Healthcare
Revenue by segment, 4 categories over 3 years. The same figures are in the table below. FY2025 Essential Dental Solutions, FY2025: 1.5B (39.9%) 40% Essential Dental Solutions Connected Technology Solutions, FY2025: 1B (28.2%) 28% Connected Technology Solutions Orthodontic and Implant Solutions, FY2025: 850M (23.1%) 23% Orthodontic and Implant Solutions Wellspect Healthcare, FY2025: 325M (8.8%) 9% FY2024 Essential Dental Solutions, FY2024: 1.5B (38.3%) 38% Connected Technology Solutions, FY2024: 1.1B (28.0%) 28% Orthodontic and Implant Solutions, FY2024: 973M (25.7%) 26% Wellspect Healthcare, FY2024: 304M (8.0%) 8% FY2023 Essential Dental Solutions, FY2023: 1.5B (37.0%) 37% Connected Technology Solutions, FY2023: 1.2B (29.5%) 29% Orthodontic and Implant Solutions, FY2023: 1B (26.2%) 26% Wellspect Healthcare, FY2023: 288M (7.3%) 7%
Segment FY2025FY2024FY2023
Essential Dental Solutions $1.47B $1.45B $1.47B
Connected Technology Solutions $1.04B $1.06B $1.17B
Orthodontic and Implant Solutions $850.0M $973.0M $1.04B
Wellspect Healthcare $325.0M $304.0M $288.0M

As the company reported it, from the “SEGMENT AND GEOGRAPHIC INFORMATION - SEGMENT REPORTING (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $3.68B$3.79B$3.96B$3.92B$4.23B$3.34B$4.02B$3.99B$3.99B$3.75B
Cost of revenue $1.84B$1.83B$1.88B$1.79B$1.88B$1.68B$1.86B$1.92B$1.80B$1.74B
Gross profit $1.84B$1.96B$2.09B$2.13B$2.35B$1.66B$2.16B$2.07B$2.19B$2.00B
R&D $150.0M$165.0M$184.0M$174.0M$171.0M$123.0M$143.0M$161.0M$151.7M$128.5M
SG&A $1.44B$1.60B$1.61B$1.59B$1.55B$1.30B$1.59B$1.72B$1.67B$1.52B
Operating income -$422.0M-$879.0M-$85.0M-$937.0M$608.0M-$3.0M$353.0M-$958.0M-$1.56B$454.7M
Interest expense $88.0M$69.0M$81.0M$65.0M$61.0M$48.0M$30.0M$37.0M$38.3M$35.9M
Pre-tax income -$486.0M-$936.0M-$175.0M-$1.05B$545.0M-$50.0M$338.0M-$958.0M-$1.60B$440.9M
Income tax $112.0M$26.0M$43.0M$105.0M$134.0M$23.0M$82.0M$53.0M$53.2M$9.5M
Net income -$598.0M-$910.0M-$132.0M-$950.0M$411.0M-$73.0M$256.0M-$1.01B-$1.55B$429.9M
EPS, basic -3.00-4.48-0.62-4.411.88-0.331.15-4.51-6.761.97
EPS, diluted -3.00-4.48-0.62-4.411.87-0.331.14-4.51-6.761.94
Shares, diluted (wtd. avg.) 199.4M203.2M212.0M215.5M220.2M219.2M224.4M224.3M229.4M221.6M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $326.0M$272.0M$334.0M$365.0M$339.0M$438.0M$405.0M$310.0M$321.0M$383.9M
Inventory $642.0M$564.0M$624.0M$627.0M$515.0M$476.0M$562.0M$598.9M$623.1M$517.1M
Total current assets $2.02B$1.75B$1.97B$1.89B$1.85B$1.80B$2.00B$1.89B$2.00B$1.74B
Property, plant and equipment ———$761.0M$773.0M$791.0M$802.0M$871.0M$876.0M$799.8M
Goodwill $1.15B$1.60B$2.44B$2.69B$3.98B$3.99B$3.40B$3.43B$4.54B$5.95B
Other intangibles $974.0M$1.21B$1.71B$1.90B$2.32B$2.50B$2.18B$2.42B$2.80B$2.96B
Total assets $5.43B$5.75B$7.37B$7.64B$9.24B$9.35B$8.60B$8.69B$10.37B$11.56B
Accounts payable $300.0M$241.0M$305.0M$279.0M$262.0M$302.0M$308.0M$283.9M$284.4M$223.0M
Short-term debt $228.0M$128.0M$77.0M$1.0M$1.0M$296.0M$0$10.6M$9.2M$11.0M
Total current liabilities $1.34B$1.59B$1.43B$1.17B$1.26B$1.37B$995.0M$1.01B$954.5M$767.6M
Long-term debt $2.02B$1.59B$1.80B$1.83B$1.91B$1.98B$1.43B$1.56B$1.61B$1.51B
Total liabilities $4.09B$3.81B$4.08B$3.83B$4.24B$4.42B$3.51B$3.55B$3.75B$3.43B
Retained earnings -$1.56B-$835.0M$205.0M$456.0M$1.51B$1.20B$1.40B$1.23B$2.32B$3.95B
Total equity $1.34B$1.94B$3.29B$3.81B$5.00B$4.93B$5.05B$5.08B$6.63B$8.13B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $235.0M$461.0M$377.0M$517.0M$657.0M$649.0M$639.0M$500.0M$601.9M$563.4M
Depreciation and amortisation $352.0M$349.0M$343.0M$328.0M$347.0M$334.0M$323.0M$331.0M$316.4M$271.7M
Stock-based compensation $33.0M$39.0M$46.0M$59.0M$48.0M$47.0M$66.0M$21.0M$48.0M$41.3M
Capital expenditure $131.0M$180.0M$149.0M$149.0M$142.0M$87.0M$123.0M$183.0M$144.3M$125.0M
Investing cash flow -$132.0M-$197.0M-$89.0M-$138.0M-$358.0M-$1.11B-$69.0M-$253.0M-$286.4M$60.0M
Financing cash flow -$80.0M-$302.0M-$307.0M-$329.0M-$379.0M$476.0M-$472.0M-$250.0M-$400.8M-$526.2M
Dividends paid $128.0M$126.0M$116.0M$104.0M$92.0M$88.0M$81.0M$79.0M$78.3M$64.6M
Buybacks $0$250.0M$300.0M$150.0M$200.0M$140.0M$260.0M$250.0M$401.4M$813.9M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000818479-26-000125.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -2B 0 2B 4B 6B Revenue, FY2016: 3.7B Gross profit, FY2016: 2B Net income, FY2016: 429.9M Revenue, FY2017: 4B Gross profit, FY2017: 2.2B Net income, FY2017: -1.6B Revenue, FY2018: 4B Gross profit, FY2018: 2.1B Net income, FY2018: -1B Revenue, FY2019: 4B Gross profit, FY2019: 2.2B Net income, FY2019: 256M Revenue, FY2020: 3.3B Gross profit, FY2020: 1.7B Net income, FY2020: -73M Revenue, FY2021: 4.2B Gross profit, FY2021: 2.3B Net income, FY2021: 411M Revenue, FY2022: 3.9B Gross profit, FY2022: 2.1B Net income, FY2022: -950M Revenue, FY2023: 4B Gross profit, FY2023: 2.1B Net income, FY2023: -132M Revenue, FY2024: 3.8B Gross profit, FY2024: 2B Net income, FY2024: -910M Revenue, FY2025: 3.7B Gross profit, FY2025: 1.8B Net income, FY2025: -598M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $3.75B $3.99B $3.99B $4.02B $3.34B $4.23B $3.92B $3.96B $3.79B $3.68B
Gross profit $2.00B $2.19B $2.07B $2.16B $1.66B $2.35B $2.13B $2.09B $1.96B $1.84B
Net income $429.9M -$1.55B -$1.01B $256.0M -$73.0M $411.0M -$950.0M -$132.0M -$910.0M -$598.0M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01
  • Regulation FD disclosure Item 7.01
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3843

TickerCompanyMarket capP/ERevenue growth
NVST Envista Holdings Corp $3.79B 84.3x 8.3%